These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 23307541)
1. Voriconazole serum concentrations in obese and overweight immunocompromised patients: a retrospective review. Davies-Vorbrodt S; Ito JI; Tegtmeier BR; Dadwal SS; Kriengkauykiat J Pharmacotherapy; 2013 Jan; 33(1):22-30. PubMed ID: 23307541 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the effect of obesity on voriconazole serum concentrations. Koselke E; Kraft S; Smith J; Nagel J J Antimicrob Chemother; 2012 Dec; 67(12):2957-62. PubMed ID: 22915462 [TBL] [Abstract][Full Text] [Related]
3. Monitoring plasma voriconazole levels may be necessary to avoid subtherapeutic levels in hematopoietic stem cell transplant recipients. Trifilio S; Pennick G; Pi J; Zook J; Golf M; Kaniecki K; Singhal S; Williams S; Winter J; Tallman M; Gordon L; Frankfurt O; Evens A; Mehta J Cancer; 2007 Apr; 109(8):1532-5. PubMed ID: 17351937 [TBL] [Abstract][Full Text] [Related]
4. Voriconazole concentrations and outcome of invasive fungal infections. Miyakis S; van Hal SJ; Ray J; Marriott D Clin Microbiol Infect; 2010 Jul; 16(7):927-33. PubMed ID: 19845698 [TBL] [Abstract][Full Text] [Related]
5. Importance of voriconazole therapeutic drug monitoring in pediatric cancer patients with invasive aspergillosis. Choi SH; Lee SY; Hwang JY; Lee SH; Yoo KH; Sung KW; Koo HH; Kim YJ Pediatr Blood Cancer; 2013 Jan; 60(1):82-7. PubMed ID: 22887791 [TBL] [Abstract][Full Text] [Related]
6. Voriconazole-related severe adverse events: clinical application of therapeutic drug monitoring in Korean patients. Kim SH; Yim DS; Choi SM; Kwon JC; Han S; Lee DG; Park C; Kwon EY; Park SH; Choi JH; Yoo JH Int J Infect Dis; 2011 Nov; 15(11):e753-8. PubMed ID: 21831685 [TBL] [Abstract][Full Text] [Related]
8. Clinician ordering practices for voriconazole therapeutic drug monitoring: experiences of a referral laboratory. Miyakis S; van Hal SJ; Solvag CJ; Ray J; Marriott D Ther Drug Monit; 2010 Oct; 32(5):661-4. PubMed ID: 20720520 [TBL] [Abstract][Full Text] [Related]